Klobuchar A Michael's Insider Trades & SAST Disclosures
Klobuchar A Michael's most recent trade in Revvity Inc. was a trade of 1,338 Common Stock done . Disclosure was reported to the exchange on April 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Klobuchar A Michael.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revvity Inc. | Michael A Klobuchar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 1,338 | 5,088 (0%) | 0% | 0 | Common Stock | |
| Revvity Inc. | Michael A Klobuchar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 1,074 | 3,750 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 127.51 per share. | 04 May 2024 | 887 | 24,058 (0%) | 0% | 127.5 | 113,101 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 887 | 0 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.51 per share. | 04 May 2024 | 437 | 23,621 (0%) | 0% | 127.5 | 55,722 | Common Stock |
| Revvity Inc. | Michael A Klobuchar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 1,218 | 2,676 (0%) | 0% | 0 | Common Stock | |
| Revvity Inc. | Michael A Klobuchar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 977 | 1,458 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 20,508 | 20,508 | - | - | Stock Option (Right to Buy) | |
| Revvity Inc. | Michael Klobuchar A | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 264 | 481 (0%) | 0% | 0 | Common Stock | |
| Revvity Inc. | A Klobuchar Michael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 217 | 217 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Klobuchar A Michael | EVP - Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 3,896 | 23,098 (0%) | 0% | 119.4 | 465,299 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.22 per share. | 04 May 2023 | 885 | 19,476 (0%) | 0% | 118.2 | 104,625 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 885 | 887 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.22 per share. | 04 May 2023 | 436 | 19,040 (0%) | 0% | 118.2 | 51,544 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 20,747 | 20,747 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 866 | 0 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 115.47 per share. | 01 May 2023 | 866 | 18,901 (0%) | 0% | 115.5 | 99,997 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.47 per share. | 01 May 2023 | 427 | 18,591 (0%) | 0% | 115.5 | 49,306 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 2,651 | 17,989 (0%) | 0% | 109.9 | 291,292 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 25,243 | 25,243 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.10 per share. | 03 May 2022 | 885 | 15,774 (0%) | 0% | 87.1 | 77,084 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 885 | 1,772 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 773 | 15,270 (0%) | 0% | 87.6 | 67,753 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 773 | 0 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.10 per share. | 03 May 2022 | 436 | 15,338 (0%) | 0% | 87.1 | 37,976 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 381 | 14,889 (0%) | 0% | 87.7 | 33,395 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 866 | 866 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.69 per share. | 01 May 2022 | 866 | 14,924 (0%) | 0% | 88.7 | 76,806 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.69 per share. | 01 May 2022 | 427 | 14,497 (0%) | 0% | 88.7 | 37,871 | Common Stock |
| Merck & Co Inc | Michael A Klobuchar | EVP - Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 2,994 | 14,058 (0%) | 0% | 73.5 | 220,089 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges